Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): a case report and literature review

Agarwal, 2020, Neurological emergencies associated with COVID-19: stroke and beyond, Emergency Radiology, 27, 10.1007/s10140-020-01837-7 Agarwal, 2020, Unusual lesion in the splenium of the corpus callosum and coronavirus infectious disease-19, BJR|case Reports, 6, 10.1259/bjrcr.20200068 Aksu Uzunhan, 2021, Cytotoxic lesions of the corpus callosum in children: Etiology, clinical and radiological features, and prognosis, Brain and Development, 43, 10.1016/j.braindev.2021.05.001 Chou, 2021, Global Incidence of Neurological Manifestations among Patients Hospitalized with COVID-19 - A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium, JAMA Network Open, 4, 10.1001/jamanetworkopen.2021.12131 Chougar, 2020, Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations, Radiology, 297, E313, 10.1148/radiol.2020202422 Dhillon, P. S., & Lenthall, R. (2020). Letter by Dhillon and Lenthall Regarding Article, “infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time.” In Stroke. https://doi.org/10.1161/STROKEAHA.120.032156 Elkhaled, 2020, A 23-year-old man with SARS-CoV-2 infection who presented with auditory hallucinations and imaging findings of cytotoxic lesions of the corpus callosum (CLOCC), American Journal of Case Reports, 21, 10.12659/AJCR.928798 Fitsiori, 2020, COVID-19 is Associated with an Unusual Pattern of Brain Microbleeds in Critically Ill Patients, Journal of Neuroimaging, 30, 10.1111/jon.12755 Garcia-Monco, 2011, Reversible Splenial Lesion Syndrome (RESLES): What's in a Name?, In Journal of Neuroimaging, 21, 10.1111/j.1552-6569.2008.00279.x Gaur, 2020, COVID-19-associated cytotoxic lesions of the corpus callosum, American Journal of Neuroradiology, 41, 10.3174/ajnr.A6713 Hacohen, 2020, Neurologic and Radiographic Findings Associated with COVID-19 Infection in Children, JAMA Neurology, 77 Harapan, 2021, Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19), Journal of Neurology, 268, 10.1007/s00415-021-10406-y Hayashi, 2020, COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion, Vol. 415 Hoshino, 2012, Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes, Brain and Development, 34, 10.1016/j.braindev.2011.07.012 Iuliano, 2022, Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods — United States, December 2020–January 2022, MMWR Recommendations and Reports, 71, 146 Klironomos, 2020, Nervous system involvement in coronavirus disease 2019: Results from a retrospective consecutive neuroimaging cohort, Radiology, 297, E324, 10.1148/radiol.2020202791 Moriguchi, 2020, A first case of meningitis/encephalitis associated with SARS-Coronavirus-2, International Journal of Infectious Diseases, 94, 55, 10.1016/j.ijid.2020.03.062 Nextstrain /ncov / gisaid / global / 6m. (n.d.). Retrieved June 19, 2022, from https://nextstrain.org/ncov/gisaid/global/6m?f_country=Japan Rasmussen, 2020, COVID-19 and involvement of the corpus callosum: Potential effect of the cytokine storm?, American Journal of Neuroradiology, 41 Sawlani, 2021, COVID-19-related intracranial imaging findings: a large single-centre experience, Clinical Radiology, 76, 10.1016/j.crad.2020.09.002 Sen, 2021, SARS-CoV-2-associated first episode of acute mania with psychotic features, Journal of Clinical Neuroscience, 87, 10.1016/j.jocn.2021.02.012 Sparr, S. A., & Bieri, P. (2020). Response by Sparr and Bieri to Letter Regarding Article, “infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time.” In Stroke. https://doi.org/10.1161/STROKEAHA.120.032521 Sriwastava, 2021, COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2, Journal of Neurology, 268, 10.1007/s00415-021-10611-9 Starkey, 2017, Cytotoxic lesions of the corpus callosum that show restricted diffusion: Mechanisms, causes, and manifestations, Radiographics, 37, 10.1148/rg.2017160085 Sun, 2019, Clinical, neuroimaging and prognostic study of 127 cases with infarction of the corpus callosum, European Journal of Neurology, 26, 1075, 10.1111/ene.13942 Tada, 2004, Clinically mild encephalitis/encephalopathy with a reversible splenial lesion, 63, 1854 Thurnher, 2021, Distinct pattern of microsusceptibility changes on brain magnetic resonance imaging (MRI) in critically ill patients on mechanical ventilation/oxygenation, Neuroradiology, 63, 10.1007/s00234-021-02663-5 Travi, 2021, Neurological manifestations in patients hospitalized with COVID-19: A retrospective analysis from a large cohort in Northern Italy, European Journal of Neuroscience, 53, 2912, 10.1111/ejn.15159 Yuan, 2017, Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review, BMC Neurology, 17, 10.1186/s12883-017-0875-5 Zhu, 2016, Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity, BMC Neurology, 16, 10.1186/s12883-016-0572-9